Brief: Aeon Biopharma Announces CEO Transition
27/03/2025 20:55
March 27 (Reuters) - Aeon Biopharma Inc AEON.A: AEON BIOPHARMA ANNOUNCES CEO TRANSITION AEON BIOPHARMA INC - MARC FORTH STEPS DOWN AS PRESIDENT AND CEO EFFECTIVE APRIL 4, 2025 AEON BIOPHARMA INC - JOST FISCHER APPOINTED INTERIM CEO Source text: ID:nGNX8CwZFY Further company coverage: AEON.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition